Newer glucose-lowering agents versus thiazolidinediones on risk of incident cirrhosis and clinical decompensation events in patients with diabetes (Second-line GLDs and liver complications)

First published 26/09/2019

Last updated 08/11/2020

EU PAS number:

EUPAS31539

Study

Finalised

Documents

Study protocol

Initial protocol

Study protocol_cirrhosis_decompensation_9-25_submitted

English (530.85 KB - PDF)View document

Study results

Yang et al, Newer second-line GLDs vs. TZDs on cirrhosis risk among older US adult patients with T2D, J Diab Complic 2020

English (988.45 KB - PDF)View document

Study report

Other information

Publications

Study publications

ENCePP Seal

ENCePP Seal documents

Secondary tabs